C-reactive protein (CRP) as a predictive marker for outcomes with avelumab + axitinib (A + Ax) in patients with poor-risk advanced renal cell carcinoma (aRCC): Exploratory analysis from JAVELIN Renal 101 Meeting Abstract


Authors: Tomita, Y.; Motzer, R. J.; Choueiri, T. K.; Rini, B. I.; Uemura, H.; Oya, M.; Albiges, L.; Fujii, Y.; Umeyama, Y.; Huang, B; Di Pietro, A.; Schmidinger, M.
Abstract Title: C-reactive protein (CRP) as a predictive marker for outcomes with avelumab + axitinib (A + Ax) in patients with poor-risk advanced renal cell carcinoma (aRCC): Exploratory analysis from JAVELIN Renal 101
Meeting Title: 2023 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 6 Suppl.
Meeting Dates: 2023 Feb 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-02-20
Language: English
DOI: 10.1200/JCO.2023.41.6_suppl.670
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 670 -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer